Post job

TerSera Therapeutics's revenue is $1.9 million.

What is TerSera Therapeutics's revenue?

TerSera Therapeutics's annual revenue is $1.9M. Zippia's data science team found the following key financial metrics about TerSera Therapeutics after extensive research and analysis.
  • TerSera Therapeutics has 135 employees, and the revenue per employee ratio is $14,074.
  • TerSera Therapeutics peak revenue was $1.9M in 2024.

On this page

Peak revenue
$1.9M (2025)
Company peak revenue
Revenue / employee
$14,074
Company revenue / employee

Zippia finds jobs where you're a top candidate and applies on your behalf.

Floating question marks illustration
Peak revenue
$1.9M (2025)
Company peak revenue
Revenue / employee
$14,074
Company revenue / employee

TerSera Therapeutics revenue FAQs

Search for jobs

Zippia gives an in-depth look into the details of TerSera Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about TerSera Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at TerSera Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by TerSera Therapeutics. The data presented on this page does not represent the view of TerSera Therapeutics and its employees or that of Zippia.

TerSera Therapeutics may also be known as or be related to TerSera Therapeutics, TerSera Therapeutics LLC and Tersera Therapeutics.